Prism Capital

Prism Capital is a private equity firm established in 1999 and located in Chicago, Illinois. The firm focuses on providing growth capital and mezzanine investments, primarily targeting businesses in the information technology, healthcare, manufacturing, and services sectors. Currently, Prism Capital is engaged in managing the winding down of its remaining fund's assets for its Limited Partners, reflecting its commitment to effective capital management and investment strategy.

Ryan Griffith

Associate

11 past transactions

Celleration

Series E in 2011
Celleration Inc. is a medical device company based in Eden Prairie, Minnesota, founded in 1999. The company specializes in developing and commercializing therapeutic ultrasound technologies for wound care. Its flagship product, the MIST Therapy System, employs low-frequency ultrasound delivered through a saline mist to promote healing by penetrating the wound bed and stimulating cellular activity. Unlike traditional wound treatments, which primarily address the surface, MIST Therapy targets deeper layers to enhance the healing process. Celleration received FDA clearance for this therapy in 2005 and has successfully introduced it to the U.S. market, demonstrating significant clinical and economic benefits across numerous healthcare facilities. To date, over one million MIST Therapy treatments have been administered, positively impacting the lives of more than 65,000 patients. The company operates as a subsidiary of Alliqua BioMedical, Inc.

Celleration

Series D in 2008
Celleration Inc. is a medical device company based in Eden Prairie, Minnesota, founded in 1999. The company specializes in developing and commercializing therapeutic ultrasound technologies for wound care. Its flagship product, the MIST Therapy System, employs low-frequency ultrasound delivered through a saline mist to promote healing by penetrating the wound bed and stimulating cellular activity. Unlike traditional wound treatments, which primarily address the surface, MIST Therapy targets deeper layers to enhance the healing process. Celleration received FDA clearance for this therapy in 2005 and has successfully introduced it to the U.S. market, demonstrating significant clinical and economic benefits across numerous healthcare facilities. To date, over one million MIST Therapy treatments have been administered, positively impacting the lives of more than 65,000 patients. The company operates as a subsidiary of Alliqua BioMedical, Inc.

ISD Corporation

Venture Round in 2005
ISD Corporation is a leading provider of secure payment management software and solutions for merchants. For over 25 years, ISD continues to deliver on its mission to provide best-of-breed software solutions which minimize merchant payment acceptance costs and secure sensitive cardholder data. As a result of its singular focus on the merchant payments market, ISD has built a base of more than 200 brand name customers across several market segments including general and specialty retail, grocery, petroleum, hospitality, government, transportation, and telecommunications

SecurePipe

Venture Round in 2004
SecurePipe, founded in 1996, provides security solutions to customers in a wide variety of industries including manufacturing, healthcare, banking, environmental response, consumer products and technology offering a three-tiered solution that combines managing, monitoring and maintaining network security. With a serious commitment to the individual customer relationship, we specialize in configuring and monitoring each system to meet the specific security needs of each customer.

HighBeam Research

Series A in 2002
HighBeam Research, Inc. is an online library and research tool designed for individuals, students, and small businesses. Founded in 2002 and headquartered in Chicago, Illinois, the company provides access to a wide range of resources, including newspaper archives, journal articles, magazine back issues, and various reference works. Its offerings encompass topics such as business, health care, education, and technology, allowing users to track industry research and trends. HighBeam Research serves a diverse clientele, including professionals seeking industry insights, students and academic staff researching for assignments, and individuals looking for information on topics like history and medical research. The platform aggregates content from reputable publishers and content providers, ensuring users can find the information they need conveniently and affordably. Since becoming a subsidiary of Gale, Inc. in 2008, HighBeam Research has also developed several blogs to provide additional content related to its research tool.

Fieldglass

Series C in 2002
Fieldglass, Inc. specializes in providing intelligent solutions for managing human capital, focusing on the procurement and management of contingent workers and services. The company offers a unified technology platform that facilitates the hiring process for managers and human resources personnel. Its primary offerings include InSite Contingent, a software-as-a-service platform that automates the entire lifecycle of contingent labor management, InSite Services for ensuring compliance in project-based engagements, and InSite Recruitment for automating direct hiring processes. Additionally, Fieldglass provides professional services such as implementation, training, and support. The company serves a diverse range of industries, including financial services, healthcare, pharmaceuticals, and telecommunications. Founded in 1999 and headquartered in Chicago, Illinois, Fieldglass has technology development offices in Naperville, Illinois, and Mumbai, India.

Celleration

Series B in 2002
Celleration Inc. is a medical device company based in Eden Prairie, Minnesota, founded in 1999. The company specializes in developing and commercializing therapeutic ultrasound technologies for wound care. Its flagship product, the MIST Therapy System, employs low-frequency ultrasound delivered through a saline mist to promote healing by penetrating the wound bed and stimulating cellular activity. Unlike traditional wound treatments, which primarily address the surface, MIST Therapy targets deeper layers to enhance the healing process. Celleration received FDA clearance for this therapy in 2005 and has successfully introduced it to the U.S. market, demonstrating significant clinical and economic benefits across numerous healthcare facilities. To date, over one million MIST Therapy treatments have been administered, positively impacting the lives of more than 65,000 patients. The company operates as a subsidiary of Alliqua BioMedical, Inc.

ProSight

Series E in 2002
ProSight specializes in providing enterprise investment management solutions tailored for government and business sectors. Its offerings combine software, services, and knowledge resources to enhance the planning and control of various business and technology investments. By implementing objective and auditable processes, ProSight facilitates collaboration among stakeholders, enabling organizations to achieve rapid results. These results include rationalizing current expenditures, optimizing support for business operations, and ensuring active governance to maximize return on investment. Through its comprehensive approach, ProSight equips information technology managers with the necessary tools for effective investment and performance management.

ProSight

Series C in 2001
ProSight specializes in providing enterprise investment management solutions tailored for government and business sectors. Its offerings combine software, services, and knowledge resources to enhance the planning and control of various business and technology investments. By implementing objective and auditable processes, ProSight facilitates collaboration among stakeholders, enabling organizations to achieve rapid results. These results include rationalizing current expenditures, optimizing support for business operations, and ensuring active governance to maximize return on investment. Through its comprehensive approach, ProSight equips information technology managers with the necessary tools for effective investment and performance management.

Motivation Online

Series A in 2000
Motivation Online provider of an internet-based behavioral business systems that systematically deploys technologies to its clients.

Service Intelligence.com

Venture Round in 2000
Service Intelligence is a prominent provider of auditing and data capture programs, serving a diverse range of industries such as retail, restaurant, grocery, pharmaceutical, education, banking, hospitality, and convenience. The company specializes in various core services, including mystery shopping, customer intelligence programs, operational audits, and compliance audits. Each program is meticulously designed to deliver accurate and comprehensive insights, enabling organizations to achieve and maintain high standards of service and operational excellence.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.